title: Non-Hodgkin's Lymphomas, version 3.2012.
abstract: These NCCN Guidelines Insights summarize several key updates to the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas (NHL) and describe the clinical evidence supporting the updates. The featured updates include changes to the recommendations for treatment options in patients with chronic lymphocytic leukemia (including in elderly or frail patients and patients with poor-risk cytogenetics), guidance surrounding surveillance imaging for follow-up of patients with NHL, and the addition of first-line consolidation options for patients with mantle cell lymphoma.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, USA.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Zelenetz
authors.forename: William G
authors.initials: WG
authors.lastname: Wierda
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Abramson
authors.forename: Ranjana H
authors.initials: RH
authors.lastname: Advani
authors.forename: C Babis
authors.initials: CB
authors.lastname: Andreadis
authors.forename: Nancy
authors.initials: N
authors.lastname: Bartlett
authors.forename: Naresh
authors.initials: N
authors.lastname: Bellam
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.forename: Myron S
authors.initials: MS
authors.lastname: Czuczman
authors.forename: Luis
authors.initials: L
authors.lastname: Fayad
authors.forename: Martha J
authors.initials: MJ
authors.lastname: Glenn
authors.forename: Jon P
authors.initials: JP
authors.lastname: Gockerman
authors.forename: Leo I
authors.initials: LI
authors.lastname: Gordon
authors.forename: Nancy Lee
authors.initials: NL
authors.lastname: Harris
authors.forename: Richard T
authors.initials: RT
authors.lastname: Hoppe
authors.forename: Steven M
authors.initials: SM
authors.lastname: Horwitz
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Kelsey
authors.forename: Youn H
authors.initials: YH
authors.lastname: Kim
authors.forename: Susan
authors.initials: S
authors.lastname: Krivacic
authors.forename: Ann S
authors.initials: AS
authors.lastname: LaCasce
authors.forename: Auayporn
authors.initials: A
authors.lastname: Nademanee
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Porcu
authors.forename: Oliver
authors.initials: O
authors.lastname: Press
authors.forename: Barbara
authors.initials: B
authors.lastname: Pro
authors.forename: Nishitha
authors.initials: N
authors.lastname: Reddy
authors.forename: Lubomir
authors.initials: L
authors.lastname: Sokol
authors.forename: Lode
authors.initials: L
authors.lastname: Swinnen
authors.forename: Christina
authors.initials: C
authors.lastname: Tsien
authors.forename: Julie M
authors.initials: JM
authors.lastname: Vose
authors.forename: Joachim
authors.initials: J
authors.lastname: Yahalom
authors.forename: Nadeem
authors.initials: N
authors.lastname: Zafar
authors.forename: Maoko
authors.initials: M
authors.lastname: Naganuma
authors.forename: Mary A
authors.initials: MA
authors.lastname: Dwyer
mesh_terms: D002986:Clinical Trials as Topic; D017408:Guidelines as Topic; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology